PLCE heads into the final day of April with one of the most compressed short structures in retail — and a stock that just shed 10% on the week, closing at $3.22.
Short sellers have been actively covering over the past two weeks, but the position they're unwinding was immense. SI peaked near 47.6% of free float on April 15, the day of the Q4 earnings print. It has since retreated to 33.6% — still an extraordinarily elevated level. The week-on-week drop of 16% in shares short is the steepest in the 30-day window, yet even after that unwind, more than one in three free-float shares remains borrowed against the stock.
The borrow market has loosened somewhat as shorts covered. Cost to borrow has eased from a 30-day high of 4.28% on April 15 to 2.84% now — still nearly triple its late-March level of around 1.0%, a reminder that the lending environment tightened sharply around earnings. Availability is not a constraint: the borrow pool has room. But the ORTEX short score of 79.2 — ranking PLCE in the 2nd percentile of all stocks for short positioning — shows the market still regards this as deeply bearish territory despite the partial cover. Days to cover from the latest FINRA settlement data run at 4.56, meaning a full unwind at average volume would take most of a trading week.
The earnings print on April 10 explains the positioning. The stock fell 21% the following session after Q4 results landed — tariff headwinds weighed on profits, according to reports. That collapse triggered the spike in short interest to near-peak levels, before a wave of covering pulled it back. The March quarter print a year prior had generated a 6.8% gain on the day, and a near 8.4% five-day move. The December 2025 print was far more brutal: a 35.9% single-day collapse. The pattern is not one of steady outcomes — PLCE around earnings is a high-volatility event stock. The next report is scheduled for June 18.
The one piece of genuinely new information this week is a strategic partnership announced April 27: PLCE named Al Othaim Life as its operating partner in Saudi Arabia, marking a re-entry into that market. The news generated modest coverage but no visible price support — the stock fell 3% on April 28 regardless. With Mithaq Capital holding 61% of shares outstanding, the effective free float is thin, which amplifies both the short interest percentage and any price moves in either direction.
The Street's only visible presence is UBS, which cut its target to $3.50 from $4.50 on April 14. That's close to the current price of $3.22, reflecting diminished conviction rather than outright bearishness. The analyst has been trimming targets consistently since late 2024 — from $18 down through $8, $5.50, and now $3.50 — a steady deterioration in expected value. Valuation is thin on traditional metrics, and with no dividend since 2019, income-focused holders are absent.
The insider signal is muted. The Chief Administration Officer sold a combined ~$29,000 in small tranches on April 15 at $3.32 — largely mechanical, given the low significance scores. The 90-day net insider position is technically a modest net buy, but that reflects the Acting CEO's $50,000 purchase at $7.00 last October — now deeply underwater. With the June 18 earnings date approaching and short interest still near a third of the float, the key question is whether covering continues at the current pace or stalls into the next catalyst.
See the live data behind this article on ORTEX.
Open PLCE on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
